BIOLIFE SOLUTIONS INC Quarterly Amortization of Intangible Assets in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Biolife Solutions Inc quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2019 to Q2 2024.
  • Biolife Solutions Inc Amortization of Intangible Assets for the quarter ending June 30, 2024 was $910K, a 35.3% decline year-over-year.
  • Biolife Solutions Inc Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $4.14M, a 39.4% decline year-over-year.
  • Biolife Solutions Inc annual Amortization of Intangible Assets for 2023 was $5.18M, a 46.6% decline from 2022.
  • Biolife Solutions Inc annual Amortization of Intangible Assets for 2022 was $9.7M, a 18.2% increase from 2021.
  • Biolife Solutions Inc annual Amortization of Intangible Assets for 2021 was $8.2M, a 170% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $4.14M $910K -$496K -35.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $4.64M $914K -$545K -37.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $5.18M $960K -$498K -34.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $5.68M $1.36M -$1.16M -46% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $6.84M $1.41M -$1.46M -50.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $8.29M $1.46M -$1.4M -49% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $9.7M $1.46M -$1.4M -49.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $11.1M $2.51M -$12K -0.48% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $11.1M $2.86M +$981K +52.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $10.1M $2.86M +$1.93M +207% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $8.2M $2.86M +$1.93M +207% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $6.27M $2.53M +$1.82M +258% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $4.45M $1.88M +$1.18M +167% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $3.28M $933K +$245K +35.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $3.03M $933K +$319K +52% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-31
Q3 2020 $2.71M $706K +$345K +95.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $2.37M $706K +$602K +579% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $1.77M $688K +$688K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $1.08M $614K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-31
Q3 2019 $361K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $104K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.